nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—MAOA—Parkinson's disease	0.801	1	CbGaD
Phenylephrine—MAOA—locus ceruleus—Parkinson's disease	0.00803	0.217	CbGeAlD
Phenylephrine—Isoprenaline—ADRBK1—Parkinson's disease	0.00247	0.343	CrCbGaD
Phenylephrine—MAOA—nerve—Parkinson's disease	0.0024	0.0648	CbGeAlD
Phenylephrine—Epinephrine—ADRBK1—Parkinson's disease	0.00207	0.288	CrCbGaD
Phenylephrine—ADRA1A—hindbrain—Parkinson's disease	0.00181	0.0489	CbGeAlD
Phenylephrine—MAOA—hindbrain—Parkinson's disease	0.0018	0.0485	CbGeAlD
Phenylephrine—ADRA1D—forebrain—Parkinson's disease	0.00175	0.0471	CbGeAlD
Phenylephrine—Norepinephrine—SLC18A2—Parkinson's disease	0.00127	0.177	CrCbGaD
Phenylephrine—MAOA—embryo—Parkinson's disease	0.00112	0.0303	CbGeAlD
Phenylephrine—ADRA1A—brainstem—Parkinson's disease	0.00104	0.028	CbGeAlD
Phenylephrine—MAOA—brainstem—Parkinson's disease	0.00103	0.0278	CbGeAlD
Phenylephrine—ADRA1B—head—Parkinson's disease	0.00102	0.0276	CbGeAlD
Phenylephrine—ADRA1A—forebrain—Parkinson's disease	0.001	0.0271	CbGeAlD
Phenylephrine—ADRA1D—head—Parkinson's disease	0.001	0.027	CbGeAlD
Phenylephrine—MAOA—forebrain—Parkinson's disease	0.000994	0.0268	CbGeAlD
Phenylephrine—ADRA1B—nervous system—Parkinson's disease	0.000969	0.0262	CbGeAlD
Phenylephrine—ADRA1D—nervous system—Parkinson's disease	0.000948	0.0256	CbGeAlD
Phenylephrine—ADRA1B—central nervous system—Parkinson's disease	0.000933	0.0252	CbGeAlD
Phenylephrine—ADRA1D—central nervous system—Parkinson's disease	0.000913	0.0246	CbGeAlD
Phenylephrine—ADRA1A—cardiovascular system—Parkinson's disease	0.000848	0.0229	CbGeAlD
Phenylephrine—MAOA—cardiovascular system—Parkinson's disease	0.00084	0.0227	CbGeAlD
Phenylephrine—ADRA1B—brain—Parkinson's disease	0.000741	0.02	CbGeAlD
Phenylephrine—ADRA1D—brain—Parkinson's disease	0.000724	0.0196	CbGeAlD
Phenylephrine—MAOA—medulla oblongata—Parkinson's disease	0.000718	0.0194	CbGeAlD
Phenylephrine—MAOA—midbrain—Parkinson's disease	0.000656	0.0177	CbGeAlD
Phenylephrine—MAOA—spinal cord—Parkinson's disease	0.00064	0.0173	CbGeAlD
Phenylephrine—ADRA1A—head—Parkinson's disease	0.000574	0.0155	CbGeAlD
Phenylephrine—MAOA—head—Parkinson's disease	0.000569	0.0154	CbGeAlD
Phenylephrine—Tapentadol—CYP2D6—Parkinson's disease	0.000546	0.0759	CrCbGaD
Phenylephrine—ADRA1A—nervous system—Parkinson's disease	0.000544	0.0147	CbGeAlD
Phenylephrine—MAOA—nervous system—Parkinson's disease	0.000539	0.0146	CbGeAlD
Phenylephrine—ADRA1A—central nervous system—Parkinson's disease	0.000524	0.0141	CbGeAlD
Phenylephrine—MAOA—central nervous system—Parkinson's disease	0.000519	0.014	CbGeAlD
Phenylephrine—ADRA1A—cerebellum—Parkinson's disease	0.000512	0.0138	CbGeAlD
Phenylephrine—MAOA—cerebellum—Parkinson's disease	0.000508	0.0137	CbGeAlD
Phenylephrine—Epinephrine—TNF—Parkinson's disease	0.000444	0.0618	CrCbGaD
Phenylephrine—ADRA1A—brain—Parkinson's disease	0.000416	0.0112	CbGeAlD
Phenylephrine—MAOA—brain—Parkinson's disease	0.000412	0.0111	CbGeAlD
Phenylephrine—Norepinephrine—DRD2—Parkinson's disease	0.000392	0.0545	CrCbGaD
Phenylephrine—ADRA1A—GPCR ligand binding—DRD3—Parkinson's disease	7.57e-05	0.000489	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PPP1R1B—Parkinson's disease	7.53e-05	0.000487	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—PDYN—Parkinson's disease	7.51e-05	0.000485	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PENK—Parkinson's disease	7.45e-05	0.000482	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—EDN1—Parkinson's disease	7.43e-05	0.000481	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	7.35e-05	0.000475	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—VPS35—Parkinson's disease	7.32e-05	0.000474	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PENK—Parkinson's disease	7.29e-05	0.000471	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	7.2e-05	0.000465	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—ADORA2A—Parkinson's disease	7.15e-05	0.000462	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	7.11e-05	0.00046	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	7.09e-05	0.000458	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—GRM4—Parkinson's disease	6.98e-05	0.000452	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—GRM5—Parkinson's disease	6.98e-05	0.000451	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—HTR7—Parkinson's disease	6.85e-05	0.000443	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—DRD2—Parkinson's disease	6.85e-05	0.000443	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—DGKQ—Parkinson's disease	6.83e-05	0.000442	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—GPR37—Parkinson's disease	6.83e-05	0.000442	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PDYN—Parkinson's disease	6.82e-05	0.000441	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PDYN—Parkinson's disease	6.67e-05	0.000431	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PENK—Parkinson's disease	6.62e-05	0.000428	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—RIT2—Parkinson's disease	6.58e-05	0.000425	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—TNF—Parkinson's disease	6.57e-05	0.000425	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—HTR2A—Parkinson's disease	6.5e-05	0.00042	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—ADORA2A—Parkinson's disease	6.49e-05	0.00042	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—COMT—Parkinson's disease	6.44e-05	0.000416	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	6.44e-05	0.000416	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	6.44e-05	0.000416	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	6.41e-05	0.000414	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	6.4e-05	0.000413	CbGpPWpGaD
Phenylephrine—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	6.35e-05	0.000411	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—GRM5—Parkinson's disease	6.34e-05	0.00041	CbGpPWpGaD
Phenylephrine—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	6.32e-05	0.000409	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—DDC—Parkinson's disease	6.3e-05	0.000407	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	6.3e-05	0.000407	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PPP1R1B—Parkinson's disease	6.25e-05	0.000404	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—GRK5—Parkinson's disease	6.24e-05	0.000403	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—HTR1A—Parkinson's disease	6.2e-05	0.000401	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—GRM5—Parkinson's disease	6.2e-05	0.000401	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—EDN1—Parkinson's disease	6.17e-05	0.000399	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—TAC1—Parkinson's disease	6.11e-05	0.000395	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—DGKQ—Parkinson's disease	6.07e-05	0.000392	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GPR37—Parkinson's disease	6.07e-05	0.000392	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PDYN—Parkinson's disease	6.06e-05	0.000391	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—DRD1—Parkinson's disease	5.99e-05	0.000387	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GSTA4—Parkinson's disease	5.95e-05	0.000385	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—ADORA2A—Parkinson's disease	5.93e-05	0.000384	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	5.89e-05	0.000381	CbGpPWpGaD
Phenylephrine—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	5.81e-05	0.000376	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—DRD3—Parkinson's disease	5.8e-05	0.000375	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HTR1A—Parkinson's disease	5.63e-05	0.000364	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—GRM5—Parkinson's disease	5.63e-05	0.000364	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—GRM4—Parkinson's disease	5.6e-05	0.000362	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PPP1R1B—Parkinson's disease	5.55e-05	0.000359	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—TAC1—Parkinson's disease	5.55e-05	0.000359	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—EDN1—Parkinson's disease	5.48e-05	0.000354	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—RIT2—Parkinson's disease	5.46e-05	0.000353	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—DRD1—Parkinson's disease	5.44e-05	0.000352	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—ADRBK1—Parkinson's disease	5.42e-05	0.00035	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—HTR2A—Parkinson's disease	5.4e-05	0.000349	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—ADORA2A—Parkinson's disease	5.39e-05	0.000348	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PLA2G6—Parkinson's disease	5.36e-05	0.000346	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PENK—Parkinson's disease	5.31e-05	0.000343	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MAG—Parkinson's disease	5.31e-05	0.000343	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—IL6—Parkinson's disease	5.3e-05	0.000343	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—MAOB—Parkinson's disease	5.3e-05	0.000343	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—ADORA2A—Parkinson's disease	5.27e-05	0.000341	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—DRD3—Parkinson's disease	5.27e-05	0.000341	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—HTR7—Parkinson's disease	5.25e-05	0.000339	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—DRD2—Parkinson's disease	5.25e-05	0.000339	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—GRK5—Parkinson's disease	5.18e-05	0.000335	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—HTR1A—Parkinson's disease	5.15e-05	0.000333	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—TAC1—Parkinson's disease	5.07e-05	0.000328	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—DRD1—Parkinson's disease	4.97e-05	0.000321	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—ADRBK1—Parkinson's disease	4.92e-05	0.000318	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—RIT2—Parkinson's disease	4.85e-05	0.000314	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PDYN—Parkinson's disease	4.85e-05	0.000314	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—DRD3—Parkinson's disease	4.82e-05	0.000311	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—HTR2A—Parkinson's disease	4.79e-05	0.00031	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—ADORA2A—Parkinson's disease	4.79e-05	0.000309	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HTR7—Parkinson's disease	4.77e-05	0.000308	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—DRD2—Parkinson's disease	4.77e-05	0.000308	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HTR1A—Parkinson's disease	4.68e-05	0.000302	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—GRM4—Parkinson's disease	4.64e-05	0.0003	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—TAC1—Parkinson's disease	4.6e-05	0.000298	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GRK5—Parkinson's disease	4.6e-05	0.000297	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—HTR1A—Parkinson's disease	4.57e-05	0.000296	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—GFAP—Parkinson's disease	4.56e-05	0.000295	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—DRD1—Parkinson's disease	4.52e-05	0.000292	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—GRM5—Parkinson's disease	4.51e-05	0.000292	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—TAC1—Parkinson's disease	4.5e-05	0.000291	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—ADRBK1—Parkinson's disease	4.5e-05	0.000291	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	4.44e-05	0.000287	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—DRD1—Parkinson's disease	4.42e-05	0.000286	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PENK—Parkinson's disease	4.4e-05	0.000285	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MAG—Parkinson's disease	4.4e-05	0.000285	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—DRD3—Parkinson's disease	4.37e-05	0.000283	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—HTR7—Parkinson's disease	4.36e-05	0.000282	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—DRD2—Parkinson's disease	4.36e-05	0.000282	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—DRD3—Parkinson's disease	4.28e-05	0.000277	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—EDN1—Parkinson's disease	4.2e-05	0.000272	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—MCCC1—Parkinson's disease	4.18e-05	0.00027	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ND3—Parkinson's disease	4.18e-05	0.00027	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HTR1A—Parkinson's disease	4.15e-05	0.000269	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GRM4—Parkinson's disease	4.13e-05	0.000267	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—TAC1—Parkinson's disease	4.09e-05	0.000264	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—ADRBK1—Parkinson's disease	4.08e-05	0.000264	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PDYN—Parkinson's disease	4.03e-05	0.00026	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—DRD1—Parkinson's disease	4.01e-05	0.000259	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	4e-05	0.000259	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—ADRBK1—Parkinson's disease	3.99e-05	0.000258	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—FGF20—Parkinson's disease	3.96e-05	0.000256	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—DRD2—Parkinson's disease	3.96e-05	0.000256	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HTR7—Parkinson's disease	3.96e-05	0.000256	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CYP2D6—Parkinson's disease	3.94e-05	0.000255	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—TALDO1—Parkinson's disease	3.93e-05	0.000254	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—OMD—Parkinson's disease	3.93e-05	0.000254	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PENK—Parkinson's disease	3.91e-05	0.000253	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MAG—Parkinson's disease	3.91e-05	0.000253	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—DRD3—Parkinson's disease	3.88e-05	0.000251	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—HTR7—Parkinson's disease	3.87e-05	0.00025	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—DRD2—Parkinson's disease	3.87e-05	0.00025	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CTGF—Parkinson's disease	3.87e-05	0.00025	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ADORA2A—Parkinson's disease	3.84e-05	0.000248	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—EDN1—Parkinson's disease	3.82e-05	0.000247	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—GFAP—Parkinson's disease	3.79e-05	0.000245	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—GRM5—Parkinson's disease	3.74e-05	0.000242	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	3.72e-05	0.000241	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—HTR2A—Parkinson's disease	3.68e-05	0.000238	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—ADRBK1—Parkinson's disease	3.63e-05	0.000235	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CYP2E1—Parkinson's disease	3.6e-05	0.000233	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PDYN—Parkinson's disease	3.58e-05	0.000231	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—NQO1—Parkinson's disease	3.56e-05	0.00023	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GCH1—Parkinson's disease	3.55e-05	0.00023	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—INSR—Parkinson's disease	3.54e-05	0.000229	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HTR7—Parkinson's disease	3.51e-05	0.000227	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—DRD2—Parkinson's disease	3.51e-05	0.000227	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—TH—Parkinson's disease	3.51e-05	0.000227	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—EDN1—Parkinson's disease	3.49e-05	0.000225	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CYCS—Parkinson's disease	3.37e-05	0.000218	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GFAP—Parkinson's disease	3.36e-05	0.000217	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—FGB—Parkinson's disease	3.35e-05	0.000216	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HTR2A—Parkinson's disease	3.34e-05	0.000216	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HTR1A—Parkinson's disease	3.33e-05	0.000215	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GRM5—Parkinson's disease	3.33e-05	0.000215	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	3.32e-05	0.000215	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—FGF20—Parkinson's disease	3.28e-05	0.000212	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TAC1—Parkinson's disease	3.28e-05	0.000212	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—DRD1—Parkinson's disease	3.21e-05	0.000208	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	3.2e-05	0.000207	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ADORA2A—Parkinson's disease	3.18e-05	0.000206	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—EDN1—Parkinson's disease	3.17e-05	0.000205	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—FBP1—Parkinson's disease	3.17e-05	0.000205	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—DBH—Parkinson's disease	3.17e-05	0.000205	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GBA—Parkinson's disease	3.17e-05	0.000205	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—DRD3—Parkinson's disease	3.11e-05	0.000201	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—EDN1—Parkinson's disease	3.1e-05	0.0002	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—HTR2A—Parkinson's disease	3.05e-05	0.000197	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—COMT—Parkinson's disease	2.99e-05	0.000193	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GSTP1—Parkinson's disease	2.97e-05	0.000192	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	2.95e-05	0.000191	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—INSR—Parkinson's disease	2.94e-05	0.00019	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—HMOX1—Parkinson's disease	2.93e-05	0.00019	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FGF20—Parkinson's disease	2.92e-05	0.000189	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ADRBK1—Parkinson's disease	2.91e-05	0.000188	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ADORA2A—Parkinson's disease	2.83e-05	0.000183	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HTR7—Parkinson's disease	2.82e-05	0.000182	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—DRD2—Parkinson's disease	2.82e-05	0.000182	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—ABCB1—Parkinson's disease	2.81e-05	0.000182	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—EDN1—Parkinson's disease	2.81e-05	0.000182	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—FGB—Parkinson's disease	2.78e-05	0.00018	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HTR2A—Parkinson's disease	2.77e-05	0.000179	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HTR1A—Parkinson's disease	2.76e-05	0.000179	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GSTM1—Parkinson's disease	2.73e-05	0.000177	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TAC1—Parkinson's disease	2.72e-05	0.000176	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—HTR2A—Parkinson's disease	2.71e-05	0.000175	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—DRD1—Parkinson's disease	2.67e-05	0.000172	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GPX1—Parkinson's disease	2.62e-05	0.000169	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—INSR—Parkinson's disease	2.61e-05	0.000169	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—DRD3—Parkinson's disease	2.58e-05	0.000167	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FGB—Parkinson's disease	2.47e-05	0.000159	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HTR2A—Parkinson's disease	2.46e-05	0.000159	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HTR1A—Parkinson's disease	2.45e-05	0.000159	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TAC1—Parkinson's disease	2.42e-05	0.000156	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—MTHFR—Parkinson's disease	2.41e-05	0.000156	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ADRBK1—Parkinson's disease	2.41e-05	0.000156	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—DRD1—Parkinson's disease	2.37e-05	0.000153	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IGF2—Parkinson's disease	2.36e-05	0.000153	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—DRD2—Parkinson's disease	2.34e-05	0.000151	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HTR7—Parkinson's disease	2.34e-05	0.000151	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—DDC—Parkinson's disease	2.32e-05	0.00015	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—DRD3—Parkinson's disease	2.29e-05	0.000148	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IGF1R—Parkinson's disease	2.28e-05	0.000147	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—EDN1—Parkinson's disease	2.25e-05	0.000146	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—APOE—Parkinson's disease	2.25e-05	0.000145	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTA4—Parkinson's disease	2.19e-05	0.000142	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.17e-05	0.00014	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ADRBK1—Parkinson's disease	2.14e-05	0.000139	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—DRD2—Parkinson's disease	2.08e-05	0.000134	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HTR7—Parkinson's disease	2.08e-05	0.000134	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NGF—Parkinson's disease	2.07e-05	0.000134	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	1.98e-05	0.000128	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HTR2A—Parkinson's disease	1.97e-05	0.000127	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IGF2—Parkinson's disease	1.96e-05	0.000127	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—MAOB—Parkinson's disease	1.96e-05	0.000126	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—INS—Parkinson's disease	1.92e-05	0.000124	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IGF1R—Parkinson's disease	1.89e-05	0.000122	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—EDN1—Parkinson's disease	1.87e-05	0.000121	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.86e-05	0.00012	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—APOE—Parkinson's disease	1.83e-05	0.000119	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	1.74e-05	0.000112	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NGF—Parkinson's disease	1.72e-05	0.000111	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	1.68e-05	0.000109	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	1.66e-05	0.000107	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HTR2A—Parkinson's disease	1.64e-05	0.000106	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—INS—Parkinson's disease	1.57e-05	0.000101	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	1.53e-05	9.87e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—APOE—Parkinson's disease	1.52e-05	9.84e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	1.45e-05	9.4e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	1.45e-05	9.4e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CTGF—Parkinson's disease	1.43e-05	9.22e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	1.35e-05	8.74e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	1.33e-05	8.59e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NQO1—Parkinson's disease	1.31e-05	8.5e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—INS—Parkinson's disease	1.3e-05	8.4e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—TH—Parkinson's disease	1.3e-05	8.38e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYCS—Parkinson's disease	1.24e-05	8.04e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CASP3—Parkinson's disease	1.17e-05	7.54e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—IL6—Parkinson's disease	1.16e-05	7.49e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—INS—Parkinson's disease	1.15e-05	7.46e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—COMT—Parkinson's disease	1.1e-05	7.12e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTP1—Parkinson's disease	1.1e-05	7.09e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—MAOA—Parkinson's disease	1.09e-05	7.07e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—HMOX1—Parkinson's disease	1.08e-05	6.99e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MAPK8—Parkinson's disease	1.07e-05	6.93e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ABCB1—Parkinson's disease	1.04e-05	6.71e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTM1—Parkinson's disease	1.01e-05	6.51e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CASP3—Parkinson's disease	9.68e-06	6.26e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GPX1—Parkinson's disease	9.65e-06	6.24e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—IL6—Parkinson's disease	9.61e-06	6.22e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—MTHFR—Parkinson's disease	8.9e-06	5.76e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MAPK8—Parkinson's disease	8.89e-06	5.75e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	8.6e-06	5.56e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	8.54e-06	5.52e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—APOE—Parkinson's disease	8.29e-06	5.36e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	7.9e-06	5.11e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—INS—Parkinson's disease	7.08e-06	4.58e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IL6—Parkinson's disease	6.84e-06	4.42e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IL6—Parkinson's disease	5.68e-06	3.67e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	5.04e-06	3.26e-05	CbGpPWpGaD
